Cellebrite
CLBT
59 hedge funds and large institutions have $249M invested in Cellebrite in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
42% more capital invested
Capital invested by funds: $175M → $249M (+$74M)
16% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $1.55M
11% more funds holding
Funds holding: 53 → 59 (+6)
0.24% more ownership
Funds ownership: 21.32% → 21.56% (+0.24%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
+$5.58M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$2.13M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$858K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$851K |
| 5 |
BlackRock
New York
|
+$792K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$6.51M |
| 2 |
IP
Isomer Partners
New York
|
-$1.82M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.2M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$655K |
| 5 |
CPM
Crescent Park Management
East Palo Alto,
California
|
-$616K |
CLBT Hedge Fund Activity: Q1 2023 in Review
59 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q1 2023, worth a combined $249M — up 42% from $175M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CLBT positions and 4 closed out — a net gain of 6 holders — while 20 added to existing stakes and 14 trimmed.
The largest buyer was Northern Right Capital Management, opening a new position worth an estimated $5.58M. The largest seller was Light Street Capital Management, cutting an estimated $6.51M.
- 59 institutional investors held Cellebrite (CLBT) as of Q1 2023, up from 53 in Q4 2022.
- Funds reported $249M of Cellebrite stock for Q1 2023, up 42% quarter-over-quarter.
- 10 funds opened new Cellebrite positions in Q1 2023 and 4 closed out, a net change of +6 holders.
- The largest Cellebrite buyer in Q1 2023 was Northern Right Capital Management, an estimated $5.58M added.
- The largest Cellebrite seller in Q1 2023 was Light Street Capital Management, an estimated $6.51M sold.
Based on aggregated 13F filings for Q1 2023.